Viral Vyas

767 total citations
15 papers, 459 citations indexed

About

Viral Vyas is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Viral Vyas has authored 15 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 2 papers in Pharmacology. Recurrent topics in Viral Vyas's work include Cancer therapeutics and mechanisms (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Cancer Treatment and Pharmacology (2 papers). Viral Vyas is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Cancer Treatment and Pharmacology (2 papers). Viral Vyas collaborates with scholars based in United States, Germany and Kuwait. Viral Vyas's co-authors include Eric H. Rubin, Aberra Fura, Patrick J. Sinko, Elora Gupta, Susan Goodin, W. Griffith Humphreys, A. H. Cornfield, T. S. Ravikumar, Lawrence G. Hamann and Lisa J. Christopher and has published in prestigious journals such as Journal of Clinical Oncology, Endocrinology and Annals of the New York Academy of Sciences.

In The Last Decade

Viral Vyas

14 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Viral Vyas United States	11	271	188	72	54	52	15	459
E. Planchat France	8	326 1.2×	233 1.2×	41 0.6×	42 0.8×	66 1.3×	16	676
Hong Lou United States	15	356 1.3×	287 1.5×	90 1.3×	47 0.9×	57 1.1×	31	857
Zhuang Miao China	8	156 0.6×	161 0.9×	53 0.7×	22 0.4×	25 0.5×	19	416
Dirk Trommeshauser Germany	14	254 0.9×	284 1.5×	156 2.2×	24 0.4×	79 1.5×	21	713
Naoaki Murao Japan	15	205 0.8×	161 0.9×	59 0.8×	34 0.6×	37 0.7×	26	624
Monicah A. Otieno United States	14	303 1.1×	83 0.4×	45 0.6×	57 1.1×	19 0.4×	27	768
Mariagrazia Distefano Italy	14	374 1.4×	265 1.4×	22 0.3×	96 1.8×	78 1.5×	20	746
Lai Wang China	11	183 0.7×	145 0.8×	119 1.7×	24 0.4×	30 0.6×	17	464
D. McKillop United Kingdom	13	248 0.9×	302 1.6×	74 1.0×	59 1.1×	45 0.9×	24	676
Xiaoguo H. Zhan United States	9	336 1.2×	133 0.7×	30 0.4×	74 1.4×	43 0.8×	9	715

Countries citing papers authored by Viral Vyas

Since Specialization

Citations

This map shows the geographic impact of Viral Vyas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viral Vyas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viral Vyas more than expected).

Fields of papers citing papers by Viral Vyas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viral Vyas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viral Vyas. The network helps show where Viral Vyas may publish in the future.

Co-authorship network of co-authors of Viral Vyas

This figure shows the co-authorship network connecting the top 25 collaborators of Viral Vyas. A scholar is included among the top collaborators of Viral Vyas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viral Vyas. Viral Vyas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Fura, Aberra, Ashish K. Khanna, Viral Vyas, et al.. (2009). Pharmacokinetics of the Dipeptidyl Peptidase 4 Inhibitor Saxagliptin in Rats, Dogs, and Monkeys and Clinical Projections. Drug Metabolism and Disposition. 37(6). 1164–1171. 86 indexed citations

Fura, Aberra, et al.. (2008). Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds. Biopharmaceutics & Drug Disposition. 29(8). 455–468. 17 indexed citations

Vyas, Viral, et al.. (2008). Primary Mediastinal Pleomorphic Rhabdomyosarcoma: A Case Report. Medical Principles and Practice. 17(2). 154–156. 2 indexed citations

Vyas, Viral, et al.. (2007). Tolerance of avastin in metastatic colorectal cancer—a single institute Kuwait Cancer Control Centre experience. Journal of Clinical Oncology. 25(18_suppl). 14156–14156.

Borzilleri, R. M., Zhen‐Wei Cai, Christopher D. Ellis, et al.. (2005). Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(5). 1429–1433. 24 indexed citations

Borzilleri, R. M., Xiaoping Zheng, Ligang Qian, et al.. (2005). Design, Synthesis, and Evaluation of Orally Active 4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Inhibitors. Journal of Medicinal Chemistry. 48(12). 3991–4008. 49 indexed citations

Arey, Brian J., Ramakrishna Seethala, Zhengping Ma, et al.. (2005). A Novel Calcium-Sensing Receptor Antagonist Transiently Stimulates Parathyroid Hormone Secretion in Vivo. Endocrinology. 146(4). 2015–2022. 44 indexed citations

Lalloo, Anita, Feng Luo, Ailan Guo, et al.. (2004). Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2). BMC Medicine. 2(1). 16–16. 54 indexed citations

Toppmeyer, Deborah, Murugesan Gounder, Viral Vyas, et al.. (2003). A phase I and pharmacologic study of the combination of marimastat and paclitaxel in patients with advanced malignancy.. PubMed. 9(8). PI99–104. 8 indexed citations

10.

Licitra, Edward, Viral Vyas, Elizabeth Poplin, et al.. (2003). Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancy.. PubMed. 9(5). 1673–9. 10 indexed citations

11.

Gupta, Elora, et al.. (2000). Pharmacokinetics of Orally Administered Camptothecins. Annals of the New York Academy of Sciences. 922(1). 195–204. 26 indexed citations

12.

Gupta, E, Feijun Luo, Alice Lallo, et al.. (2000). The intestinal absorption of camptothecin, a highly lipophilic drug, across Caco-2 cells is mediated by active transporter(s).. PubMed. 20(2A). 1013–6. 24 indexed citations

13.

Vyas, Viral, A. H. Cornfield, Susan Goodin, et al.. (1999). In vitro activation of irinotecan to SN-38 by human liver and intestine.. PubMed. 19(3A). 2067–71. 50 indexed citations

14.

DiPaola, Robert S., Mohamed M. Rafi, Viral Vyas, et al.. (1999). Phase I Clinical and Pharmacologic Study of 13-cis-Retinoic Acid, Interferon Alfa, and Paclitaxel in Patients With Prostate Cancer and Other Advanced Malignancies. Journal of Clinical Oncology. 17(7). 2213–2213. 44 indexed citations

15.

Vyas, Viral, Ahamed Saleem, A. H. Cornfield, et al.. (1998). High-performance liquid chromatographic quantitation of total and lactone 20(S)camptothecin in patients receiving oral 20(S)camptothecin. Journal of Chromatography B Biomedical Sciences and Applications. 707(1-2). 227–233. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact